Integer Holdings Reaches Cooperation Agreement With Activist Investor

Integer Holdings ( (ITGR) ) has provided an update.

On March 9, 2026, Integer Holdings entered into a cooperation agreement with Irenic Capital Management that led to the appointment of James Flanagan and investor representative Aaron Kapito as independent directors, with their Board roles effective March 12, 2026. Two incumbent directors will not stand for re-election at the 2026 annual meeting, Board size will be capped at 13 before that meeting and 11 thereafter during the cooperation period, and Irenic has withdrawn its competing director slate and agreed to standstill and voting commitments, signaling a negotiated truce with an activist investor aimed at strengthening governance and sharpening the company’s focus on growth and long-term value creation.

Flanagan, the former Chief Operating Officer of PwC, joins the Audit and Technology Strategy Committees, while Kapito, a partner at Politan Capital Management with a background in activist and value-oriented investing, will sit on the Compensation and Organization Committee and the Technology Strategy Committee. The agreement gives Irenic ongoing Board representation subject to ownership thresholds and committee approval, reflecting growing activist influence in the medical device CDMO space and potentially aligning Integer’s capital allocation, strategic planning, and governance more closely with shareholder priorities as it targets improving organic sales growth in 2026 and beyond.

The most recent analyst rating on (ITGR) stock is a Hold with a $92.00 price target. To see the full list of analyst forecasts on Integer Holdings stock, see the ITGR Stock Forecast page.

Spark’s Take on ITGR Stock

According to Spark, TipRanks’ AI Analyst, ITGR is a Neutral.

The score is driven primarily by solid underlying financial performance (steady growth and positive cash generation) tempered by balance-sheet and margin-quality watch items. Near-term outlook from the earnings call adds caution due to modest 2026 growth and expected margin pressure early in the year. Technicals are mixed-to-weak versus key moving averages, and valuation appears demanding with a ~34.7 P/E and no dividend yield provided.

To see Spark’s full report on ITGR stock, click here.

More about Integer Holdings

Integer Holdings Corporation, headquartered in Plano, Texas and listed on the NYSE under the ticker ITGR, is one of the largest global medical device contract development and manufacturing organizations. The company serves cardio and vascular, neuromodulation, and cardiac rhythm management markets through brands including Greatbatch Medical and Lake Region Medical, positioning itself as a strategic partner to leading medical device makers and emerging innovators.

Average Trading Volume: 778,282

Technical Sentiment Signal: Sell

Current Market Cap: $2.94B

For detailed information about ITGR stock, go to TipRanks’ Stock Analysis page.